Author

Peter Karl Jacobsen

Observed names: Jacobsen, Peter, Jacobsen, Peter Karl, P Jacobsen, P K Jacobsen, P Karl Jacobsen, P. Jacobsen, P. K. Jacobsen, P. Karl Jacobsen, P.K Jacobsen, P.K. Jacobsen, PETER K. JACOBSEN, PETER KARL JACOBSEN, Peter Jacobsen, Peter K Jacobsen, Peter K. Jacobsen, Peter Karl K Jacobsen

Institutions: Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet

Observed institutions: University of Copenhagen, Western University, Steno Diabetes Centers, Inserm, University of Southern Denmark, Aarhus University, Helsinki University Hospital, London Health Sciences Centre, Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet, Capital Region of Denmark, Steno Diabetes Center Copenhagen

ORCID: 0000-0002-1520-8774

Observed ORCID: 0000-0002-1520-8774

OpenAlex ID: A5083703658

Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

2024 · Emmanuel Ekanem, Petr Neuzil, et al. · Nature Medicine · 520

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

2003 · Peter Jacobsen, Steen Andersen, et al. · Kidney International · 226

Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy

2003 · Kasper Rossing, Peter Jacobsen, et al. · Diabetes Care · 225

Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy

2003 · Peter Jacobsen, Steen Andersen, et al. · Journal of the American Society of Nephrology · 209

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

1996 · Hans-Henrik Parving, Peter Jacobsen, et al. · BMJ · 185

Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy

2000 · P. Clausen, P. Jacobsen, et al. · Diabetic Medicine · 150

Pregnancy and progression of diabetic nephropathy

2002 · K. Rossing, P. Jacobsen, et al. · Diabetologia · 128

Unchanged Incidence of Diabetic Nephropathy in IDDM Patients

1995 · Peter Rossing, Kasper Rossing, et al. · Diabetes · 128

Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy

2002 · P. Jacobsen · Nephrology Dialysis Transplantation · 126

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

1998 · Peter Jacobsen, Kasper Rossing, et al. · Kidney International · 107

Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients

2012 · Stine E. Nielsen, Henrik Reinhard, et al. · Diabetes Research and Clinical Practice · 102

Progression of diabetic nephropathy in normotensive type 1 diabetic patients

1999 · Peter Jacobsen, Kasper Rossing, et al. · Kidney International · 99

Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study

2008 · Søren Søgaard Lund, Lise Tarnow, et al. · PLoS ONE · 92

35th Annual Meeting of the European Association for the Study of Diabetes

1999 · A. Melander, J. Olsson, et al. · Diabetologia · 86

Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic Nephropathy

2003 · Peter Jacobsen, Lise Tarnow, et al. · Journal of the American Society of Nephrology · 85

Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.

1998 · J A Fagerudd, L Tarnow, et al. · Diabetes · 81

Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy

1999 · F. S. Nielsen, H. P. Hansen, et al. · Diabetic Medicine · 74

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy

1996 · Hans-Henrik Parving, Peter Jacobsen, et al. · Kidney International · 70

40th EASD Annual Meeting of the European Association for the Study of Diabetes

2004 · M. Veitenhansl, K. Stegner, et al. · Diabetologia · 66

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

2018 · Daniel G.K. Rasmussen, Tine W. Hansen, et al. · Diabetes Care · 65

Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register

2013 · P. Weeke, J. B. Johansen, et al. · EP Europace · 64

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

2004 · Hans-Henrik Parving, Steen Andersen, et al. · Seminars in Nephrology · 62

Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria

2015 · Bernt Johan von Scholten, Henrik Reinhard, et al. · Journal of Diabetes and its Complications · 60

Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate

2011 · Christel Joergensen, Henrik Reinhard, et al. · Diabetes Care · 54

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

2017 · Emilie H. Zobel, Bernt Johan von Scholten, et al. · Cardiovascular Diabetology · 53

Works count: 150

Citation count: 4,495

H-index: 35

I10-index: 72